CPOCX
Price
$16.42
Change
+$0.75 (+4.79%)
Updated
May 12 closing price
Net Assets
1.31B
RGEBX
Price
$72.14
Change
+$2.64 (+3.80%)
Updated
May 12 closing price
Net Assets
285.48B
Ad is loading...

CPOCX vs RGEBX

Header iconCPOCX vs RGEBX Comparison
Open Charts CPOCX vs RGEBXBanner chart's image
Morgan Stanley Insight L
Price$16.42
Change+$0.75 (+4.79%)
VolumeN/A
Net Assets1.31B
American Funds Growth Fund of Amer R2E
Price$72.14
Change+$2.64 (+3.80%)
VolumeN/A
Net Assets285.48B
CPOCX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CPOCX vs. RGEBX commentary
May 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CPOCX is a Buy and RGEBX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 285B vs. CPOCX (1.31B). CPOCX pays higher dividends than RGEBX: CPOCX (1.61) vs RGEBX (0.00). CPOCX was incepted earlier than RGEBX: CPOCX (28 years) vs RGEBX (11 years). CPOCX (1.64) is less costly to investors than RGEBX (1.09). CPOCX is a more actively managed with annual turnover of: 44.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than CPOCX: RGEBX (250) vs CPOCX (1000). CPOCX annual gain was more profitable for investors over the last year : 52.49 vs. RGEBX (2.34). RGEBX return over 5 years is better than : 44.21 vs. CPOCX (-56.05).
CPOCXRGEBXCPOCX / RGEBX
Total Expense Ratio1.641.09150%
Annual Report Gross Expense Ratio1.641.09150%
Fund Existence28 years11 years-
Gain YTD-0.571-2.71621%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.31B285B0%
Annual Yield % from dividends1.610.00-
Returns for 1 year52.492.342,242%
Returns for 3 years-19.1828.81-67%
Returns for 5 years-56.0544.21-127%
Returns for 10 years-44.5653.32-84%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OXBR1.970.32
+19.29%
Oxbridge Re Holdings Limited
PENN15.970.33
+2.11%
PENN Entertainment
TRVI6.700.10
+1.52%
Trevi Therapeutics
RPRX33.350.20
+0.60%
Royalty Pharma plc
SAMG14.44-0.06
-0.41%
Silvercrest Asset Management Group